Menu

Cancer Pharmacology Research Program

Program Leaders: X. F. Steven Zheng, PhD and Stephen K. Burley, MD, DPhil
 

Overall Goals:

To discover and develop more effective cancer treatments through pharmacology-based preclinical research. The guiding principal is that a fundamental understanding of the biology of molecular targets in cancer is key for discovering and developing innovative therapeutic strategies and for overcoming drug resistance.

Specific Aims:

  • To understand the biology of key molecular targets in cancer that drive cell growth, proliferation, and survival so that they can be effectively targeted for cancer therapy.
  • To determine the modes of action and mechanisms of resistance to anticancer agents. 
  • To discover and develop novel therapeutics and drug delivery technologies for more effective cancer treatment. 

Collaborating Research Programs:

Useful Links:

 

 

precision medicine at Rutgers Cancer Institute

 

 

 

ScreenNJ

 

 

Donate Now

 

 

 


 

 

 

 

Proud member of
Big Ten Cancer Research Consortium

 

 

Rutgers Health